R-138727

Approval Year

PubMed

PubMed

Show entries

Title	Date	PubMed
Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.	2005 Sep	16268477

Showing 1 to 1 of 1 entries

Substance Class	Mixture
Record UNII	FLN02B3F1J
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

R-138727

Common Name

English

R-138727 [MI]

Common Name

English

(2Z)-2-(1-(2-CYCLOPROPYL-1-(2-FLUOROPHENYL)-2-OXOETHYL)-4-MERCAPTO-3-PIPERIDINYLIDENE) ACETIC ACID

Systematic Name

English

ACETIC ACID, 2-(1-(2-CYCLOPROPYL-1-(2-FLUOROPHENYL)-2-OXOETHYL)-4-MERCAPTO-3-PIPERIDINYLIDENE)-, (2Z)-

Systematic Name

English

Showing 1 to 4 of 4 entries

Previous1Next

Show entries

Code System

Code

Type

Description

EPA CompTox

DTXSID20699475

PRIMARY

MERCK INDEX

m9103

PRIMARY

Merck Index

FDA UNII

FLN02B3F1J

PRIMARY

CAS

204204-73-9

PRIMARY

PUBCHEM

10405534

PRIMARY

Showing 1 to 5 of 5 entries

Previous1Next

All of the following components must be present:


					QP6CO5BO8X

R-125690


					CBH764R26K

R-125687


					N2AQA3AO11

R-125688


					97EDJ67519

R-125689

Show entries

Related Record

Type

Details


					34K66TBT99

PRASUGREL

PRODRUG -> METABOLITE ACTIVE

Interaction Type:

MAJOR

Qualification:

PLASMA

Amount:

122 ng-hour/mL (average)


					G89JQ59I13

PRASUGREL HYDROCHLORIDE

PRODRUG -> METABOLITE ACTIVE

Showing 1 to 2 of 2 entries

Previous1Next